GLP1R and type 2 diabetes mellitus: As reviewed and further discussed in Arden (2018), there is clear evidence that GLP-1 agonists enhance the function of autophagy in various peripheral tissues, which mediates the survival of pancreatic β-cells during hyperglycaemia and T2DM.